Information Provided By:
Fly News Breaks for June 6, 2018
ALKS
Jun 6, 2018 | 04:54 EDT
B. Riley FBR analyst David Buck started Alkermes with a Buy rating and $60 price target. The analyst sees the company's self-marketed drugs driving its future growth.
News For ALKS From the Last 2 Days
There are no results for your query ALKS